Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.36%40.13B | 47.08%9.17B | -24.56%10.98B | -9.10%38.83B | 48.86%6.53B | -39.30%11.51B | -29.39%6.23B | 38.11%14.56B | 2.22%42.71B | -75.58%4.38B |
| Cost of revenue | 0.12%30.37B | 54.37%7.07B | -26.65%8.61B | -11.62%30.34B | 43.19%5.05B | -41.83%8.97B | -34.51%4.58B | 39.97%11.74B | 1.55%34.32B | -76.15%3.53B |
| Gross profit | 14.93%9.76B | 26.88%2.1B | -15.82%2.37B | 1.21%8.49B | 72.24%1.47B | -28.27%2.54B | -9.86%1.65B | 30.89%2.82B | 5.02%8.39B | -72.96%855.75M |
| Operating expense | 12.88%4.47B | 29.84%1.17B | 5.14%1.12B | -0.99%3.96B | -14.51%961.33M | 3.05%1.03B | 2.30%904.52M | 7.34%1.07B | -2.50%4B | -2.85%1.12B |
| Staff costs | 6.83%1.52B | ---- | ---- | -12.04%1.42B | ---- | ---- | ---- | ---- | 12.59%1.62B | ---- |
| Selling and administrative expenses | 16.97%1.28B | ---- | ---- | 4.79%1.1B | ---- | ---- | ---- | ---- | -8.79%1.05B | ---- |
| -Selling and marketing expense | 20.19%1.08B | ---- | ---- | 1.87%900.34M | ---- | ---- | ---- | ---- | -9.73%883.85M | ---- |
| -General and administrative expense | 2.16%200.25M | ---- | ---- | 20.72%196.02M | ---- | ---- | ---- | ---- | -3.30%162.37M | ---- |
| Depreciation and amortization | -1.05%24.74M | ---- | ---- | 0.13%25.01M | ---- | ---- | ---- | ---- | -6.36%24.97M | ---- |
| -Depreciation | -1.05%24.74M | ---- | ---- | 0.13%25.01M | ---- | ---- | ---- | ---- | -6.36%24.97M | ---- |
| Rent and land expenses | -7.39%29.37M | ---- | ---- | 5.85%31.72M | ---- | ---- | ---- | ---- | 13.48%29.96M | ---- |
| Other operating expenses | 16.58%1.61B | ---- | ---- | 8.10%1.38B | ---- | ---- | ---- | ---- | -12.61%1.28B | ---- |
| Operating profit | 16.72%5.29B | 23.31%923.45M | -28.57%1.25B | 3.22%4.53B | 290.76%512.61M | -40.54%1.51B | -21.18%748.86M | 51.05%1.75B | 12.97%4.39B | -113.39%-268.71M |
| Net non-operating interest income (expenses) | -20.01%-866.77M | 2.14%-191.36M | -34.25%-249.42M | 10.75%-722.27M | 9.03%-164.2M | 43.01%-176.73M | -23.13%-195.55M | -16.23%-185.79M | -9.45%-809.28M | -3.80%-180.49M |
| Non-operating interest income | 3,088.37%8.23M | 1,095.70%1.11M | 19.64%67K | 6.17%258K | -3.90%74K | 66.67%35K | 1.09%93K | 5.66%56K | 4.29%243K | 16.67%77K |
| Non-operating interest expense | 22.19%749.46M | 16.24%179.71M | 16.01%171.85M | 4.77%613.36M | 17.42%155.16M | 7.55%155.46M | 0.85%154.61M | -4.70%148.14M | -8.08%585.43M | -17.13%132.15M |
| Total other finance cost | 14.99%125.53M | -68.89%12.77M | 105.87%77.63M | -51.29%109.17M | -81.18%9.11M | -87.13%21.31M | 631.27%41.04M | 746.65%37.71M | 118.11%224.1M | 234.37%48.42M |
| Net investment income | -42.07%3.29M | -52.10%2.16M | -88.69%368K | 8.40%5.68M | -995.91%-4.82M | 2.74M | 144.37%4.5M | -78.07%3.26M | -63.34%5.24M | -79.90%538K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -26.26%9.4M | 123.60%12.75M | -322.61%-54.01M | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 460.01%81.06M | 2,460.91%86.41M | -255.48%-5.79M | 125.92%14.47M | 112.43%7.38M | 0 | -81.69%3.37M | 43.21%3.72M | -246.53%-55.85M | 36.70%-59.35M |
| Less:Other special charges | -833.07%-81.06M | -2,460.91%-86.41M | 255.48%5.79M | -115.56%-8.69M | -102.68%-1.59M | --0 | 81.69%-3.37M | -43.21%-3.72M | 142.35%55.85M | --59.35M |
| Less:Write off | --0 | ---- | ---- | ---5.79M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -4.30%-17.64M | -5,793.10%-3.42M | -42.48%1.22M | -57.37%-16.92M | -96.27%-42.62M | 436.95%23.63M | -101.29%-58K | 2.11%2.13M | -45.24%-10.75M | -208.17%-21.71M |
| Income before tax | 17.60%4.5B | 45.64%817.23M | -36.65%999.25M | 10.38%3.82B | 155.00%321.09M | -38.66%1.36B | -30.21%561.12M | 54.50%1.58B | 9.01%3.46B | -133.90%-583.75M |
| Income tax | 16.00%1.37B | 47.64%260.98M | -34.78%313.2M | 9.52%1.18B | 166.03%103.72M | -38.11%422.87M | -30.58%176.77M | 60.14%480.24M | 28.72%1.08B | -141.04%-157.08M |
| Net income | 18.32%3.12B | 44.72%556.25M | -37.47%686.05M | 10.77%2.64B | 150.95%217.37M | -38.90%939.9M | -30.04%384.35M | 52.15%1.1B | 1.93%2.38B | -131.86%-426.67M |
| Net income continuous operations | 18.32%3.12B | 44.72%556.25M | -37.47%686.05M | 10.77%2.64B | 150.95%217.37M | -38.90%939.9M | -30.04%384.35M | 52.15%1.1B | 1.93%2.38B | -131.86%-426.67M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 18.32%3.12B | 44.72%556.25M | -37.47%686.05M | 10.77%2.64B | 150.95%217.37M | -38.90%939.9M | -30.04%384.35M | 52.15%1.1B | 1.93%2.38B | -131.86%-426.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 18.32%3.12B | 44.72%556.25M | -37.47%686.05M | 10.77%2.64B | 150.95%217.37M | -38.90%939.9M | -30.04%384.35M | 52.15%1.1B | 1.93%2.38B | -131.86%-426.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 19.68%284.51 | 46.75%50.82 | -37.07%62.2 | 10.77%237.73 | 150.94%19.58 | -38.90%84.68 | -30.04%34.63 | 52.16%98.84 | 1.93%214.61 | -131.86%-38.44 |
| Diluted earnings per share | 19.68%284.51 | 46.63%50.7741 | -37.07%62.2 | 10.77%237.73 | 150.94%19.58 | -38.90%84.6776 | -30.04%34.6269 | 52.16%98.84 | 1.93%214.61 | -131.86%-38.44 |
| Dividend per share | 20.69%70 | 0.00%26 | 0 | 16.00%58 | 14.29%32 | 0 | 18.18%26 | 0 | 25.00%50 | 27.27%28 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |